Beth Israel Lahey Health Awarded Grant to Power New High Performance Computing Cluster<\/p>\n
Newswise \u2014 Boston, MA \u2014 Beth Israel Lahey Health (BILH) is expanding its research computing power with a new High Performance Computing (HPC) cluster designed to accelerate discovery and drive the next generation of data-powered precision medicine. \u00a0<\/p>\n
From genomic sequencing that generates terabytes of data to advanced imaging, artificial intelligence and predictive modeling, BILH researchers are working with rapidly growing datasets. The expanded computing power will help BILH move faster from insight to impact -advancing new treatments, strengthening clinical research, and improving care for patients.<\/p>\n
Enabled by a Dell Technologies grant, this modernized HPC Cluster includes advanced compute, networking, enhanced GPU capabilities and expansive data storage, supported with Dell Technologies Services. This initiative builds on the long-standing partnership between the two organizations and underscores Dell\u2019s commitment to supporting BILH in driving innovation, discovery, research and more.<\/p>\n
\u201cWith this groundbreaking technology, our research teams will build an HPC cluster that can process and analyze enormous amounts of data at speeds far beyond our current capabilities,\u201d said Gyongyi Szabo, MD, PhD, chief academic officer for Beth Israel Lahey Health and Beth Israel Deaconess Medical Center. \u201cHaving advanced resources available across the system will help ensure every researcher has access to the tools to turn ideas into impact, which is especially important for innovative large-scale data projects.\u201d<\/p>\n
An initial focus of the HPC cluster will be strengthening large data set analysis and clinical trial recruitment through AI-enhanced tools. Recruiting patients for clinical trials is one of the biggest bottlenecks in medical research. Building on Beth Israel Deaconess Medical Center\u2019s Informatics for Integrating Biology & the Bedside (i2b2) system, the new HPC capabilities will revolutionize clinical trial matching and accelerate enrollment in trials, reducing delays and promoting equitable access to innovative therapies across oncology, neurology, cardiology, infectious diseases and beyond.<\/p>\n
\u201cWorking with BILH represents a significant opportunity to shape the future of AI-driven medicine,\u201d said Fran Bogle, senior vice president, Healthcare & Higher Education, Dell Technologies. \u201cBy equipping researchers and clinicians with cutting-edge technology, we\u2019re enabling innovation that drives human progress. Together, we can power a new era of discovery and care, where advanced computing leads to improved outcomes for patients around the world.\u201d<\/p>\n
The Dell Technologies grant will significantly expand BILH\u2019s high-performance computing infrastructure and research capacity, while strengthening the system\u2019s contributions to initiatives such as the Massachusetts AI Hub.<\/p>\n
\u201cWe are enormously grateful to Dell for supporting Beth Israel Lahey Health,\u201d said Kristine Laping, chief development officer for BILH. \u201cPublic-private partnership plays a critical role in advancing medical research – fueling the infrastructure and innovation needed to bring discoveries from the lab to the bedside. This technology equips our researchers with powerful new tools to translate data and ideas into improved care for patients and communities.\u201d<\/p>\n
###<\/p>\n","protected":false},"excerpt":{"rendered":"Beth Israel Lahey Health Awarded Grant to Power New High Performance Computing Cluster Newswise \u2014 Boston, MA \u2014…\n","protected":false},"author":2,"featured_media":103492,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[33],"tags":[1405,36012,36008,36009,948,9195,37,22726,36007,36010,36011,947],"class_list":["post-103491","post","type-post","status-publish","format-standard","has-post-thumbnail","category-israel","tag-artificial-intelligence","tag-beth-israel-lahey-health","tag-biotech","tag-budgets-and-funding","tag-education","tag-engineering","tag-israel","tag-newswise","tag-precision-medicinegenomic-sequencing-technologygenomic-sequencingadvanced-imagingartificial-intelligence-aitechnology","tag-stem-education","tag-supercomputing","tag-technology"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@iran\/116537382852059002","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/iran\/wp-json\/wp\/v2\/posts\/103491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/iran\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/iran\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/iran\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/iran\/wp-json\/wp\/v2\/comments?post=103491"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/iran\/wp-json\/wp\/v2\/posts\/103491\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/iran\/wp-json\/wp\/v2\/media\/103492"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/iran\/wp-json\/wp\/v2\/media?parent=103491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/iran\/wp-json\/wp\/v2\/categories?post=103491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/iran\/wp-json\/wp\/v2\/tags?post=103491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}